US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

HUGE FSD Pharma Inc

0.2991

-0.0109 (-3.52%)

31 May 2024 - Cerrado

Retrasado por 15 minutos

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

nullnull

FSD Pharma (NASDAQ:HUGE)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas FSD Pharma.

FSD Pharma (NASDAQ:HUGE)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas FSD Pharma.

Noticias sobre FSD Pharma Inc HUGE

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Viernes 31 de Mayo 2024 (2 días hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martes 20 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case
Jueves 11 de Enero 2024 (5 meses hace) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Jueves 4 de Enero 2024 (5 meses hace) • Edgar (US Regulatory)

InvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin Harrington
Viernes 22 de Septiembre 2023 (8 meses hace) • GlobeNewswire Inc.

FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW)
Viernes 25 de Agosto 2023 (9 meses hace) • Business Wire

InvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
Jueves 3 de Agosto 2023 (10 meses hace) • GlobeNewswire Inc.

Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201
Lunes 17 de Julio 2023 (11 meses hace) • Business Wire

FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock
Lunes 10 de Julio 2023 (11 meses hace) • Business Wire

FSD Pharma Appoints Zeeshan Saeed as Chief Executive Officer, Anthony Durkacz to Serve as Executive Co-Chairman of the Board of Directors
Martes 4 de Julio 2023 (11 meses hace) • Business Wire

FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
Viernes 30 de Junio 2023 (11 meses hace) • Business Wire

InvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly Nutrition
Viernes 23 de Junio 2023 (11 meses hace) • GlobeNewswire Inc.

Más de FSD Pharma Inc Artículos de Noticias

GRANITE SFNG INAV

The Italian Sea

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones